NASDAQ: SLXN
Silexion Therapeutics Corp Stock Ownership - Who owns Silexion Therapeutics?

Insider buying vs selling

Have Silexion Therapeutics Corp insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SLXN insiders and whales buy or sell their stock.

SLXN Shareholders

What type of owners hold Silexion Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Moringa Sponsor LP33.07%2,875,000$2.00MInsider
Ilan Levin33.07%2,875,000$2.00MInsider
Wildcat Capital Management LLC1.30%113,428$78.83kInstitution
Ubs Group Ag0.84%72,874$50.65kInstitution
Meyer Handelman Co0.38%32,967$22.91kInstitution
Sbi Securities Co Ltd0.19%16,411$11.41kInstitution
Bank Of America Corp0.01%500$347.50Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution
Hudson Bay Capital Management LP0.00%0$0.00Insider
Amnon Peled0.00%0$0.00Insider

1 of 1

SLXN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SLXN2.72%66.15%
CLRB56.65%43.35%Net BuyingNet Buying
APLM0.22%0.00%
NLSP5.36%0.00%
GNPX1.38%18.31%Net SellingNet Selling

Silexion Therapeutics Stock Ownership FAQ

Who owns Silexion Therapeutics?

Silexion Therapeutics (NASDAQ: SLXN) is owned by 2.72% institutional shareholders, 66.15% Silexion Therapeutics insiders, and 31.13% retail investors. Moringa Sponsor LP is the largest individual Silexion Therapeutics shareholder, owning 2.88M shares representing 33.07% of the company. Moringa Sponsor LP's Silexion Therapeutics shares are currently valued at $2.47M.

If you're new to stock investing, here's how to buy Silexion Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.